Table 3: Antimicrobial susceptibility of the isolated organisms of necrotizing fasciitis patients.
|
Organism |
Patients number |
Antimicrobial |
Susceptibility rate |
|
Staphylococcus aureus |
259 |
Ampicillin-Sulbactam |
100% |
|
Clindamycin |
100% |
||
|
Vancomycin |
100% |
||
|
Pseudomonas aeruginosa
|
216
|
Piperacillin-tazobactam |
100% |
|
Amikacin |
100% |
||
|
|
|
Imipenem |
100% |
|
Staphylococcus Epidermidis |
194 |
Ceftazidime |
100% |
|
Tazobactam |
98% |
||
|
Enterococcus species |
172 |
Amikacin |
100% |
|
Ceftriaxone |
94% |
||
|
Klebsiella pneumoniae |
136 |
Cefuroxim |
97% |
|
Imipenem-cilastatin |
95% |
||
|
Bacteroides |
113 |
Clindamycin |
100% |
|
Vancomycin |
100% |
||
|
Proteus mirabilis |
107 |
Cefoxitin |
90% |
|
Acinetobacter |
82 |
Imipenem |
95% |
|
Citrobacter species |
64 |
Imipenem |
90% |
|
Alcaligenes faecalis |
47 |
Trimethoprim-sulfamethoxazole |
85% |
|
Beta-hemolytic streptococcus |
56 |
Trimethoprim-sulfamethoxazole |
90% |
|
Bacitracin |
90% |
||
|
Escherichia coli |
41 |
Piperacillin-tazobactam |
100% |
|
Cefuroxime |
100% |
||
|
Ampicillin |
100% |
||
|
Clostridium difficile |
23 |
Metronidazole |
100% |
|
Vancomycin |
100% |